@FierceBiotech: AstraZeneca CEO celebrates 1st anniversary with promising lung cancer data. More | Follow @FierceBiotech
@JohnCFierce: Pfizer nabs autoimmune disease drug rights for $25M upfront. News | Follow @JohnCFierce
@DamianFierce: Few are optimistic about a last-minute budget deal. Here's what happens at the FDA after a shutdown: Article | Follow @DamianFierce
> When it launched in March 2011, Bristol-Myers' ($BMY) Yervoy became the only drug ever to extend survival in patients with advanced forms of melanoma. Now, new data show just how long the breakthrough drug can extend that survival: A few patients using Yervoy could tack on as much as a decade to their lives, according to a long-term study. And more than a few could see a few extra years. Story
> The EMA has accepted AstraZeneca's ($AZN) application for naloxegol, triggering a $25 million milestone payday for Nektar Therapeutics. A nod from the FDA next would be worth another $70 million. Report
> Ariad Pharmaceuticals ($ARIA) presented updated Phase I/II data on its TKI drug AR26113 for non-small cell lung cancer. Release
Pharma News
@FiercePharma: Trending on our website (still): If pharma reps can't get in doctors' front doors, try alternate routes. Story | Follow @FiercePharma
@EricPFierce: U.K. tosses lean, but important bone to pharma with expected extension of cancer drug fund. ICYMI Friday | Follow @EricPFierce
@CarlyHFierce: Bristol-Myers melanoma drug Yervoy helps patients live years longer, study finds. Story | Follow @CarlyHFierce
> Germany's Bayer taps Pfizer's Olivier Brandicourt to head Bayer HealthCare. News
> Look out, pharma marketers. Obamacare will change your lives. More
> Roche CEO: 'Extremely' open to talk with Novartis about teaming up. Article
@FierceMedDev: Device tax at center of government funding battle. Article | Follow @FierceMedDev
@MarkHFierce: KKR made it official, grabbing an 80% stake of Panasonic's healthcare arm for $1.67B - much higher than predicted. ICYMI Friday | Follow @MarkHFierce
@MichaelGFierce: ICYMI: Medtronic lands U.S. approval of early-generation artificial pancreas. Story from FierceDrugDelivery | Follow @MichaelGFierce
> Intersect plugs positive drug-eluting sinus implant data. Item
> Life Tech to peddle Advanced Cell Diagnostics' RNA biomarker tech around the world. More
> KCI absorbs two acquisitions into wound care mega-company. Article
CRO News
> Quintiles jumps into personalized medicine for cancer trials. More
> Merged at last, PRA and RPS say they're fourth-largest CRO. Report
> InVentiv launches doc network for late-stage trials. Story
> JSS snaps up Latin American CRO. Article
> Parexel launches China-focused service as local demand heats up. News
Biotech IT News
> FDA taking hands-off approach to regulation of most apps. More
> Genohub talks up 'Kayak' for NGS services. Report
> NIH calls for comments on draft genomics data sharing policy. Story
> Business behind Google Earth for the human body raises $4M. Item
> Pfizer to give patients access to their trial data. Article
And Finally... Want to help protect your children from allergies and hypersensitivities? Raise them on a farm. Release